Pacing decisions guided by risk for pacing-induced heart muscle weakness
Official title: Pacing Advancements With Cost and Experience VALuation for Unified Patient-Led Clinical Evidence - the PACEVALUE Study
Run by Insel Gruppe AG, University Hospital Bern · NCT07276139 · Data updated 2026-11-12
This study tests a risk score to predict pacing-induced cardiomyopathy in adults getting heart rhythm devices, to tailor pacing choices.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 4500 (estimated) |
| Sponsor | Insel Gruppe AG, University Hospital Bern Academic / other |
| Locations | 13 sites (Canberra, Australian Capital Territory and 12 other locations) |
| Status | Recruiting |
| Started | January 1, 2026 |
| Main results expected | January 1, 2028 |
| Study ends | January 1, 2031 |
| Registry record updated | September 11, 2026 |
| Trial ID | NCT07276139 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) receiving or having received a cardiac implantable electronic device (pacemaker, ICD, or CRT) and who consent to participate and complete long-term follow-up.
✕Probably not a fit
Patients in whom a high-quality predictive signal cannot be derived or who do not fit the prospective cohort may not benefit from risk-guided pacing decisions.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
PACEVALUE is an international observational effort to use routinely collected clinical and device data to predict who is at highest risk of pacing-induced cardiomyopathy after device implantation. The study aims to help physicians personalize pacing strategies, including conduction system pacing and cardiac resynchronization therapy, to minimize complications and hospitalizations. It will develop and validate a risk model that can be applied in prospective patients and use retrospective data to support its performance. The initiative involves adults undergoing pacemakers, ICDs, or CRT devices and follows participants over time to observe outcomes related to heart function and device performance.
Why it matters
Potential benefit: If successful, the risk model could help clinicians choose pacing approaches that reduce heart failure risk and improve long-term outcomes.
How similar studies have gone: Prior work in risk stratification for device-related outcomes has shown promise, but this specific predictive approach for PICM-guided pacing is still being validated.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years at the time of the CIED procedure * Undergoing, or having undergone, a CIED procedure (permanent pacemaker, ICD, or CRT) * A lawful basis for inclusion: signed informed consent prior to enrollment in the prospective arm, or a lawful basis for the further use of health-related personal data in the retrospective arm * Prospective arm only: willing and able to participate in long-term follow-up * Prospective arm only: sufficient language comprehension (or support) to provide informed consent and complete PROMs/PREMs Exclusion Criteria: * Prospective arm only: severe cognitive impairment without a legal representative * A documented objection to the use of health-related data for research
Where it's running
-
Canberra Health Services
Canberra, Australian Capital Territory, Australia Recruiting -
Inselspital, University Hospital Bern
Bern, Switzerland Recruiting -
Acibadem City Clinic Tokuda Hospital
Sofia, Bulgaria Not yet recruiting -
University Hospital Tsaritsa Yoanna ISUL
Sofia, Bulgaria Not yet recruiting -
Dubrava University Hospital
Zagreb, Croatia Not yet recruiting -
Nicosia General Hospital
Nicosia, Cyprus Not yet recruiting
Show 7 more locations
-
University Heart Center Freiburg-Bad Krozingen
Bad Krozingen, Germany Not yet recruiting -
Clinical Provincial Hospital No. 2
Rzeszów, Poland Not yet recruiting -
National Institute of Cardiology
Warsaw, Poland Not yet recruiting -
4th Military Clinical Hospital
Wroclaw, Poland Not yet recruiting -
Medical University of Silesia
Zabrze, Poland Not yet recruiting -
Kantonsspital Baden
Baden, Switzerland Not yet recruiting -
Hôpitaux Universitaires de Genève
Geneva, Switzerland Not yet recruiting
Study contacts
- Principal investigator: Nikola A. Kozhuharov, PD Dr. med. — Inselspital, University Hospital Bern, Clinic of Cardiology
- Study coordinator: Nikola A. Kozhuharov, PD Dr. med.
- Email: nikola.kozhuharov@insel.ch
- Phone: +41 31 63 2 36 50
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pace-and-ablate strategy in atrial fibrillation: who benefits and long-term outcomes
This study looks at adults with atrial fibrillation who underwent AV node ablation with permanent pacing to see who develops pacing-induced problems and how they do long-term.
-
Conduction system pacing vs biventricular pacing for CRT
This study tests whether pacing the heart’s conduction system (HIS or left bundle) during CRT works better than standard biventricular pacing for people with heart failure.
-
Left bundle branch area pacing with Tendril STS or UltiPace leads
This study will try left bundle branch area pacing with the Tendril STS or UltiPace lead in adults who need pacemaker leads for bradycardia or related heart conditions to see if pacing and sensing are safe and work through six months after implant.
-
Understanding brain and heart injuries after bleeding in the brain
This study looks at how bleeding in the brain affects both the brain and the heart in adults to better understand the connection between these injuries.
-
Using Apple Watch data to predict heart failure outcomes
This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.
-
Comparing two pacing methods for heart failure in patients with atrial fibrillation
This study is testing whether a new pacing method for the heart can work better than the standard method for people with heart failure and atrial fibrillation.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.